A. Nowak

发表

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

V. Budach, A. Abdollahi, I. Tinhofer, 2022, Cancers.

Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection: A Retrospective Cohort Study

J. Ursing, P. Nowak, A. Nowak, 2019, International journal of microbiology.

Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG.

I. Tinhofer, S. Löck, M. Krause, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.

V. Budach, F. Buchholz, J. Debus, 2020, The Journal of molecular diagnostics : JMD.

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.

D. Aust, J. Steinbach, F. Buchholz, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Total body irradiation before bone marrow transplantation: aims and results.

J. Malicki, J. Wachowiak, G. Stryczyńska, 2001, Advances in experimental medicine and biology.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

D. Aust, V. Budach, F. Buchholz, 2016, Clinical Cancer Research.

Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.

V. Budach, A. Abdollahi, I. Tinhofer, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

V. Budach, F. Buchholz, J. Debus, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

D. Aust, V. Budach, F. Buchholz, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy

V. Budach, F. Buchholz, J. Debus, 2018, Clinical Cancer Research.

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

F. Buchholz, S. Löck, M. Krause, 2019, Clinical and translational radiation oncology.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy

F. Buchholz, S. Löck, M. Krause, 2016, Clinical and translational radiation oncology.

Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy.

V. Budach, A. Abdollahi, I. Tinhofer, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.